Global Pharmaceuticals & Biotech Top Growth Stocks

GNI Group

Market Cap: JP¥133.8b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.5b

Shanghai Rightongene Biotechnology Co., Ltd.

Devyser Diagnostics

Market Cap: SEK 1.9b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Invivyd

Market Cap: US$559.5m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

SIGA Technologies

Market Cap: US$425.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Insmed

Market Cap: US$44.1b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Everest Medicines

Market Cap: HK$15.9b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

ST PharmLtd

Market Cap: ₩2.0t

Provides manufacturing services for active pharmaceutical ingredient and intermediate.

Cosmo Pharmaceuticals

Market Cap: CHF 1.0b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

BioGaia

Market Cap: SEK 10.1b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BeOne Medicines

Market Cap: US$36.8b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Medexus Pharmaceuticals

Market Cap: CA$87.9m

Operates as a pharmaceutical company in Canada and the United States.

Krystal Biotech

Market Cap: US$6.2b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Unicycive Therapeutics

Market Cap: US$118.6m

A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.

Rezolute

Market Cap: US$905.9m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Ardelyx

Market Cap: US$1.3b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

InnoCare Pharma

Market Cap: HK$28.3b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

CanSino Biologics

Market Cap: HK$14.1b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Japan Tissue Engineering

Market Cap: JP¥19.7b

Engages in the regenerative medicine business in Japan.

Strides Pharma Science

Market Cap: ₹81.6b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥16.0b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

Photocure

Market Cap: NOK 1.6b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

Tarsus Pharmaceuticals

Market Cap: US$3.5b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

Prelude Therapeutics

Market Cap: US$115.4m

A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

Day One Biopharmaceuticals

Market Cap: US$911.8m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Journey Medical

Market Cap: US$205.7m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Earth Science Tech

Market Cap: US$39.5m

Together with its subsidies, focuses on health and wellness industry.

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥14.4b

Engages in research, development, production, and sales of blood products in China.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Guard Therapeutics International

Market Cap: SEK 26.8m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Geron

Market Cap: US$740.5m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Annexon

Market Cap: US$652.7m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Avadel Pharmaceuticals

Market Cap: US$2.2b

Operates as a biopharmaceutical company in the United States.

Zai Lab

Market Cap: US$2.2b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.